Please assess the completion status of the following clinical trial:

Trial Title: Combined Haploidentical-Cord Blood Transplantation for Adults and Children

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Patients will be eligible for this study if they have any one of the diseases that are known to be cured after allogeneic stem cell transplantation.~1. Relapsed or refractory acute leukemia (myeloid or lymphoid)~2. Acute leukemia in first remission at high-risk for recurrence~3. Chronic myelogenous leukemia in accelerated phase or blast-crisis~4. Chronic myelogenous leukemia in chronic phase~5. Recurrent or refractory malignant lymphoma or Hodgkin lymphoma~6. Chronic lymphocytic leukemia, relapsed or with poor prognostic features~7. Multiple myeloma~8. Myelodysplastic syndrome~9. Chronic myeloproliferative disease~10. Hemoglobinopathies~11. Aplastic anemia~Exclusion Criteria:~1. Zubrod performance status \> 2~2. Life expectancy is severely limited by concomitant illness~3. Patients with severely decreased LVEF or impaired pulmonary function tests(PFT's)~4. Estimated Creatinine Clearance \<50 ml/min~5. Serum bilirubin\> 2.0 mg/dl or SGPT \>3 x upper limit of normal~6. Evidence of chronic active hepatitis or cirrhosis~7. HIV-positive~8. Patient is pregnant~9. Patient or guardian not able to sign informed consent

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Good Risks patients (Type: EXPERIMENTAL): For patients transplanted in remission.
- High Risk Patients eligible for radiation (Type: EXPERIMENTAL): None
- High Risk Patients not eligible for radiation (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).